PreOmics GmbH

Personalized medicine employs accurate measurements of parameters like proteins from cells e.g. biopsies and body fluids like blood plasma or urine. This results in an increased demand for diagnostic products and new technologies for analyses. Mass spectrometry (MS) – based proteomics allows the sensitive and accurate quantification of almost complete proteomes of complex biological fluids and tissues. PreOmics develops Technologies, Assays and consumables to enable and establish MS-based proteomics in research, biomarker discovery and clinical diagnostics.